McKesson Corporation
MCK
Rank in Stocks
#189
McKesson Corporation is a prominent global provider of healthcare services,... McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.
Share Price
$1,017.66
Market Cap
$118.65B
Change (1 day)
0.60%
Change (1 year)
29.17%
Country
US
Trade McKesson Corporation (MCK)
Category
Healthcare
Revenue for McKesson Corporation (MCK)
Revenue in Jun 2026 TTM: $410.98B
According to McKesson Corporation latest financial reports the company's current revenue (TTM) is $410.98B. In 2024 the company made a revenue of $308.95B an increase over the revenue in the year 2023 that was $276.71B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for McKesson Corporation from 2000 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $410.98B | 14.46% |
| 2025 | $359.05B | 16.22% |
| 2024 | $308.95B | 11.65% |
| 2023 | $276.71B | 4.83% |
| 2022 | $263.97B | 10.80% |
| 2021 | $238.23B | 3.11% |
| 2020 | $231.05B | 7.81% |
| 2019 | $214.32B | 2.86% |
| 2018 | $208.36B | 4.95% |
| 2017 | $198.53B | 4.01% |
| 2016 | $190.88B | 6.61% |
| 2015 | $179.05B | 30.11% |
| 2014 | $137.61B | 12.38% |
| 2013 | $122.46B | -0.23% |
| 2012 | $122.73B | 9.50% |
| 2011 | $112.08B | 3.11% |
| 2010 | $108.70B | 1.94% |
| 2009 | $106.63B | 4.85% |
| 2008 | $101.70B | 9.39% |
| 2007 | $92.98B | 5.60% |
| 2006 | $88.05B | 9.36% |
| 2005 | $80.51B | 15.84% |
| 2004 | $69.51B | 21.68% |
| 2003 | $57.12B | 14.23% |
| 2002 | $50.01B | 19.03% |
| 2001 | $42.01B | 14.36% |
| 2000 | $36.73B | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| - | - |
US
|
|
| $254.25B | -38.14% |
US
|
|
| - | - |
US
|
|
| $7.64B | -98.14% |
AU
|
|
| $13.60B | -96.69% |
US
|
